Nitric oxide mediates cyclosporine-induced apoptosis in cultured renal cells

被引:61
作者
Amore, A
Emanicpator, SN
Cirina, P
Conti, G
Ricotti, E
Bagheri, N
Coppo, R
机构
[1] Regina Margherita Childrens Hosp, Dept Nephrol & Dialysis, Div Nefrol & Dialisi, I-10126 Turin, Italy
[2] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
关键词
cyclosporine A; cell death; nephrotoxicity; NO; fibrogenesis;
D O I
10.1046/j.1523-1755.2000.00999.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background The clinical use of cyclosporine (CsA) is limited by its nephrotoxicity. Apoptosis, perhaps instigated by increased nitric oxide synthase (NOS) activity,may play a role in such toxicity. Methods. Human mesangial cells, human tubular cells, human umbilical vein endothelial cells, or murine endothelial cells were cultured with CsA at final concentrations of 0 to 1000 ng/mL for 4 to 24 hours. As inhibitors of apoptosis, 0.01 mol/L L-nitromethylarginine (L-NAME) or 1 mu g/mL cycloheximide (CHX) was added, whereas 0.01 mol/L sodium nitroprusside (as a nitric oxide donor) was used as a positive control. Apoptosis was assessed by using TUNEL method and by DNA fragmentation by electrophoresis. In addition, NOS enzymatic activity, Northern blots for inducible NOS (iNOS) mRNA, and immunohistochemically demonstrable iNOS protein were evaluated. Results. Within 12 to 24 hours, CsA significantly increased the fraction (8 to 35%) of apoptotic cells in each cell line, according to the dose. Fragmentation of DNA confirmed apoptosis. L-NAME and CHX inhibited the phenomenon, whereas sodium nitroprusside enhanced it. Each cell line significantly increased NOS activity in response to CsA, an effect blunted by L-NAME and CHX. Neither inhibitor modified the increased iNOS mRNA expression elicited by CsA. Positive staining for both iNOS and p53 proteins was observed in all cell lines incubated with CsA that were inhibited by CHX; L-NAME inhibited only p53 staining. Conclusions. CsA induces apoptosis in various renal cell lines, and this effect is mediated by the induction of iNOS via p53. These effects may contribute to the acellular fibrosis characteristic of late CsA nephrotoxicity.
引用
收藏
页码:1549 / 1559
页数:11
相关论文
共 60 条
[11]   ALTERNATIVE CYCLOSPORINE METABOLIC PATHWAYS AND TOXICITY [J].
CHRISTIANS, U ;
SEWING, KF .
CLINICAL BIOCHEMISTRY, 1995, 28 (06) :547-559
[12]   PROSTANOID-INDUCED EXPRESSION OF MATRIX METALLOPROTEINASE-1 MESSENGER-RIBONUCLEIC-ACID IN RAT OSTEOSARCOMA CELLS [J].
CLOHISY, JC ;
CONNOLLY, TJ ;
BERGMAN, KD ;
QUINN, CO ;
PARTRIDGE, NC .
ENDOCRINOLOGY, 1994, 135 (04) :1447-1454
[13]  
Cutolo M, 1998, CLIN EXP RHEUMATOL, V16, P417
[14]  
ELDEIRY WS, 1994, CANCER RES, V54, P1169
[15]   Visualization of cyclosporin A and Ca2+-sensitive cyclical mitochondrial depolarizations in cell culture [J].
Fall, CP ;
Bennett, JP .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1999, 1410 (01) :77-84
[16]   PROGRESSIVE GROWTH IN IMMUNODEFICIENT MICE AND HOST-CELL RECRUITMENT BY MOUSE ENDOTHELIAL-CELLS TRANSFORMED BY POLYOMA MIDDLE-SIZED T-ANTIGEN - IMPLICATIONS FOR THE PATHOGENESIS OF OPPORTUNISTIC VASCULAR TUMORS [J].
GARLANDA, C ;
PARRAVICINI, C ;
SIRONI, M ;
DEROSSI, M ;
DECALMANOVICI, RW ;
CAROZZI, F ;
BUSSOLINO, F ;
COLOTTA, F ;
MANTOVANI, A ;
VECCHI, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (15) :7291-7295
[17]   NITRIC-OXIDE - PATHOPHYSIOLOGICAL MECHANISMS [J].
GROSS, SS ;
WOLIN, MS .
ANNUAL REVIEW OF PHYSIOLOGY, 1995, 57 :737-769
[18]   Apoptosis and expression of Bax protein and Fas antigen in glomeruli of a remnant-kidney model [J].
Hattori, T ;
Shindo, S ;
Kawamura, H .
NEPHRON, 1998, 79 (02) :186-191
[19]   NUCLEAR SIGNALING BY ENDOTHELIN-1 - A RAS PATHWAY FOR ACTIVATION OF THE C-FOS SERUM RESPONSE ELEMENT [J].
HERMAN, WH ;
SIMONSON, MS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (19) :11654-11661
[20]   Glucocorticoids and cyclosporine induce apoptosis in mitogen-activated human peripheral mononuclear cells [J].
Horigome, A ;
Hirano, T ;
Oka, K ;
Takeuchi, H ;
Sakurai, E ;
Kozaki, K ;
Matsuno, N ;
Nagao, T ;
Kozaki, M .
IMMUNOPHARMACOLOGY, 1997, 37 (01) :87-94